
New U.S. data based on nearly 9 million doses of the Pfizer-BioNTech COVID-19 vaccine delivered to kids ages 5 to 11 shows no major safety issues, according to researchers at the U.S. Centers for Disease Control and Prevention. The vaccine was first authorized for use in this age group in October. Now the new study… read on > read on >